International Journal of Gynecological Cancer

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
International Journal of Gynecological Cancer - Tập 7 Số 1 - Trang 42-45 - 1997
Tugan Beşe, Fuat Demirkıran, Macit Arvas, A U Oz, D. Kösebay, Engin Erkün
Endometrial carcinoma Stage I-Grade II. Conservative treatment followed by a healthy twin pregnancy
International Journal of Gynecological Cancer - Tập 8 Số 2 - Trang 172-174 - 1998
Zuckerman, Lavie, Neuman, Tom Rabinowitz, Ben-Chetrit, Henry Bech Mathiesen, Rosenmann, Beller
The Use of “Optimal Cytoreduction” Nomenclature in Ovarian Cancer Literature: Can We Move Toward a More Optimal Classification System?
International Journal of Gynecological Cancer - Tập 26 Số 8 - Trang 1421-1427 - 2016
Ana M. Angarita, Rebecca L. Stone, Sarah M. Temkin, Kimberly Levinson, Amanda N. Fader, Edward J. Tanner
ObjectivesThe objective of this study is to explore how cytoreductive surgical outcomes such as residual disease (RD) and use of the term “optimal cytoreduction” (OCR) have changed over time in the ovarian cancer literature.MethodsWe identified all English-language publications referring to ovarian cancer cytoreduction for a 12-year period. Publications were evaluated for how the diameter of RD wa... hiện toàn bộ
Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update
International Journal of Gynecological Cancer - Tập 26 Số 9 - Trang 1650-1657 - 2016
Giuseppe Laurelli, Francesca Falcone, Maria Stella Gallo, Felice Scala, Simona Losito, Vincenza Granata, Marco Cascella, Stefano Greggi
ObjectiveThis study aimed to analyze the long-term oncologic and reproductive outcomes in endometrial cancer (EC) in young patients conservatively treated by combined hysteroscopic resection (HR) and levonorgestrel intrauterine device (LNG-IUD).MethodsTwenty-one patients (age ≤ 40 years; Stage IA, G1-2 endometrioid EC), wishing to preserve their fertility, were enrolled into this prospective study... hiện toàn bộ
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer
International Journal of Gynecological Cancer - Tập 27 Số 4 - Trang 738-742 - 2017
Ji Young Hwang, Da Hee Kim, Hyo Sook Bae, Mi‐La Kim, Yong Wook Jung, Bo Seong Yun, Seok Ju Seong, Eunah Shin, Mi Kyoung Kim
ObjectiveThe aim of this study was to evaluate the oncologic and pregnancy outcomes of combined oral medroxyprogesterone acetate (MPA)/levonorgestrel-intrauterine system (LNG-IUS) treatment in young women with grade 2–differentiated stage IA endometrial adenocarcinoma who wish to preserve fertility.MethodsWe retrospectively reviewed the medical records of patients with grade 2 stage IA endometrial... hiện toàn bộ
Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer
International Journal of Gynecological Cancer - Tập 15 Số 2 - Trang 319-324 - 2005
Andreas Obermair, Tom Manolitsas, Yee Leung, Ian Hammond, Anthony J. McCartney
First-Line Therapy in Ovarian Cancer Trials
International Journal of Gynecological Cancer - Tập 21 Số 4 - Trang 756-762 - 2011
Tate Thigpen, Andreas duBois, Jessica N. McAlpine, Philip J. DiSaia, Keiichi Fujiwara, William J. Hoskins, Gunnar B. Kristensen, Robert S. Mannel, Maurie Markman, Jacobus Pfisterer, Michael Quinn, Nick Reed, Ann Marie Swart, Jonathan S. Berek, Nicoletta Colombo, Gilles Freyer, Dolores Gallardo, Marie Plante, Andrés Poveda, Larry Rubinstein, Monica Bacon, Henry C Kitchener, Gavin Stuart
At the 4th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG) held in Vancouver, Canada, in June 2010, representatives of 23 cooperative research groups studying gynecologic cancers gathered to establish international consensus on issues critical to the conduct of large randomized trials. The process focused on 13 predetermined questions. Group A, 1 of the 3 discussion... hiện toàn bộ
Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
International Journal of Gynecological Cancer - Tập 21 Số 4 - Trang 763-770 - 2011
Jonathan A. Ledermann, Christian Marth, Mark S. Carey, Michael J. Birrer, David D.L. Bowtell, Stan B. Kaye, Iain A. McNeish, Amit M. Oza, Giovanni Scambia, Gordon Rustin, Frederick B. Stehman, David M. Gershenson, Gillian Thomas, Els M.J.J. Berns, Antonio Casado, Nelleke Ottevanger, Felix Hilpert, Byoung‐Gie Kim, Aikou Okamoto, Monica Bacon, Henry C Kitchener, Gavin Stuart
There is now a greater understanding of the molecular pathways in ovarian cancer, and using this knowledge, a large number of new therapeutic agents can be tested. The success of these drugs will depend on selecting drugs that target known key dysfunctional molecular pathways. To make best use of these compounds, prognostic and predictive biomarkers need to be identified. Novel methods of assessme... hiện toàn bộ
Multi-institutional phase 2 study of TLK286 (TELCYTAtm, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
International Journal of Gynecological Cancer - Tập 15 Số 4 - Trang 593-600 - 2005
J J Kavanagh, David M. Gershenson, Hyun Jin Choi, Lionel D. Lewis, Kiran Klaus Patel, Geoffrey L. Brown, Agustin A. García, David R. Spriggs
Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/ déphosphorylation in plasma membrane from human epithelial ovarian cancer
International Journal of Gynecological Cancer - Tập 3 Số 5 - Trang 311-317 - 1993
Atsushi Imai, Shigeo Ohno, Tatsuro Furui, Kozo Takahashi, T. Matsuda, T Tamaya
Tổng số: 73   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8